Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edwards Lifesciences (EW)
NYSE:EW
EW Stock Chart & Stats
Day’s Range― - ―
52-Week Range$58.93 - $96.12
Previous CloseN/A
Volume821.68K
Average Volume (3M)4.46M
Market Cap
$44.63B
Enterprise Value$35.79B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)10.7
Beta1.31
Next Earnings
Apr 24, 2025EPS Estimate
0.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.97
Shares Outstanding589,800,000
10 Day Avg. Volume4,258,578
30 Day Avg. Volume4,457,160
Standard Deviation0.10
R-Squared0.36
Alpha-0.00852
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.50
Price to Cash Flow (P/CF)31.30
P/FCF Ratio34.50
Enterprise Value/Market Cap0.80
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.74
Enterprise Value/Ebitda21.02
Forecast
1Y Price Target
$79.17Price Target Upside5.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering23
---
Bulls Say, Bears Say
Bulls Say
EarningsEW delivered 4Q results that outpaced Street expectations.
Growth OpportunitiesEW is considered one of the more attractive Medtech growth opportunities.
Product PerformanceEW is pleased with S3 Ultra Resilia's commercial performance in both the US and Europe.
Bears Say
Growth LimitationsOngoing capacity constraints are likely to weigh on TAVR growth and potentially limit the degree to which upside from near-term growth drivers could be seen.
GuidanceThe company reiterated the FY25 guidance ranges, which may dampen investor enthusiasm on EW's strong 4Q performance.
Sales ProjectionsQ1 guidance brackets Street, though total company and TAVR growth expected to be below.
---
Ownership Overview
0.93% Insiders
21.34% Mutual Funds
18.83% Other Institutional Investors
34.42% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EW FAQ
What was Edwards Lifesciences’s price range in the past 12 months?
Edwards Lifesciences lowest stock price was $58.93 and its highest was $96.12 in the past 12 months.
What is Edwards Lifesciences’s market cap?
Edwards Lifesciences’s market cap is $44.63B.
When is Edwards Lifesciences’s upcoming earnings report date?
Edwards Lifesciences’s upcoming earnings report date is Apr 24, 2025 which is in 62 days.
How were Edwards Lifesciences’s earnings last quarter?
Edwards Lifesciences released its earnings results on Feb 11, 2025. The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.551 by $0.039.
Is Edwards Lifesciences overvalued?
According to Wall Street analysts Edwards Lifesciences’s price is currently Undervalued.
Does Edwards Lifesciences pay dividends?
Edwards Lifesciences does not currently pay dividends.
What is Edwards Lifesciences’s EPS estimate?
Edwards Lifesciences’s EPS estimate is 0.6.
How many shares outstanding does Edwards Lifesciences have?
Edwards Lifesciences has 589,800,000 shares outstanding.
What happened to Edwards Lifesciences’s price movement after its last earnings report?
Edwards Lifesciences reported an EPS of $0.59 in its last earnings report, beating expectations of $0.551. Following the earnings report the stock price went up 6.924%.
Which hedge fund is a major shareholder of Edwards Lifesciences?
Currently, no hedge funds are holding shares in EW
---
Edwards Lifesciences Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$79.17 (5.97% Upside)
$79.17 (5.97% Upside)
Blogger Sentiment
Bullish
EW Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 780.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days >0.1%
Last 30 Days ▲ 0.9%
Last 30 Days ▲ 0.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-14.02%
12-Months-Change
Fundamentals
Return on Equity
43.57%
Trailing 12-Months
Asset Growth
38.42%
Trailing 12-Months
Company Description
Edwards Lifesciences
Incorporated in 1958, California-based Edwards Lifesciences Corp. is a medical technology company, which specializes in structural heart disease and critical care and surgical monitoring. It reports in three segments: Transcatheter Aortic Valve Replacements, Transcatheter Mitral and Tricuspid Therapies and Surgical Structural Heart and Critical Care.
---
EW Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive sentiment with strong sales growth, especially in TMTT, strategic acquisitions, and a positive outlook for future growth. Despite some challenges in TAVR growth and regional pressures, the company maintained a strong balance sheet and is optimistic about 2025.Read More>---
EW Net sales Breakdown
64.61% Transcatheter Aortic Valve Replacement
16.64% Surgical Structural Heart
15.46% Critical Care
3.29% Transcatheter Mitral and Tricuspid Therapies
---
EW Stock 12 Month Forecast
Average Price Target
$79.17
▲(5.97% Upside)
Technical Analysis
Best Analysts Covering EW
1 Year
1 Year Success Rate
22/32 ratings generated profit
1 Year Average Return
+11.24%
reiterated a buy rating 3 months ago
Copying Suraj Kalia's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +11.24% per trade.
---